GlassScriptPhysician profile
Kelly Whelan
NPI 1245917483
$1,654.58
in general payments reported to CMS, 2019-2025
21 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $1,090 · 2024: $565.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,639 · Education: $15.10.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,639.48 |
| Education | $15.10 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $412.83 | 2023-2024 | Mounjaro, Jardiance, Zepbound |
| Novo Nordisk INC | $272.26 | 2023-2024 | Ozempic, Rybelsus, Tresiba |
| Sanofi-Aventis U.S. LLC | $167.57 | 2023-2024 | |
| Astrazeneca Pharmaceuticals LP | $122.88 | 2023 | Farxiga |
| Tandem Diabetes Care, INC. | $118.06 | 2023-2024 | T:Slim X2 Insulin Pump With Control-Iq |
| Amgen INC. | $64.74 | 2023-2024 | Evenity, Prolia |
| Mannkind Corporation | $61.86 | 2023-2024 | Afrezza |
| Corcept Therapeutics | $60.36 | 2023 | Korlym |
| Bayer Healthcare Pharmaceuticals INC. | $60.21 | 2023-2024 | |
| Radius Health, INC. | $58.44 | 2023-2024 | |
| Dexcom, INC. | $40.85 | 2023-2024 | Dexcom G6 Transmitter |
| Alexion Pharmaceuticals, INC. | $37.15 | 2023-2024 | Strensiq |
| Insulet Corporation | $30.38 | 2023-2024 | Omnipod |
| Tolmar, INC. | $22.63 | 2023 | |
| Amryt Pharma Holdings LTD | $22.26 | 2023 | Mycapssa |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi Pasteur INC. | $19.67 | 2024 | |
| Rgh Enterprises LLC | $19.34 | 2024 | |
| Ibsa Pharma INC. | $16.52 | 2024 | Licart, Tirosint |
| Amneal Pharmaceuticals LLC | $16.17 | 2023 | Unithroid |
| Lexicon Pharmaceuticals, INC. | $15.30 | 2023 | Inpefa |
| Opko Pharmaceuticals, LLC | $15.10 | 2023 | Rayaldee |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kelly Whelan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.